AA
BNTX icon

AlphaMark Advisors’s BioNTech BNTX Stock Holding History

AlphaMark Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$4K Sell
35
-130
-79% -$14.8K ﹤0.01% 524
2024
Q3 		$20K Buy
165
+95
+136% +$8.73K 0.01% 430
2024
Q2 		$6K Sell
70
-50
-42% -$4.57K ﹤0.01% 588
2024
Q1 		$11K Sell
120
-100
-45% -$9.59K ﹤0.01% 517
2023
Q4 		$23K Hold
220
– – 0.01% 430
2023
Q3 		$24K Hold
220
– – 0.01% 406
2023
Q2 		$24K Buy
220
+50
+29% +$5.62K 0.01% 294
2023
Q1 		$21K Sell
170
-50
-23% -$6.87K 0.01% 308
2022
Q4 		$33K Hold
220
– – 0.02% 243
2022
Q3 		$30K Hold
220
– – 0.01% 256
2022
Q2 		$33K Hold
220
– – 0.02% 259
2022
Q1 		$38K Hold
220
– – 0.01% 259
2021
Q4 		$57K Buy
220
+50
+29% +$13.7K 0.02% 223
2021
Q3 		$46K Hold
170
– – 0.02% 242
2021
Q2 		$38K Sell
170
-80
-32% -$15.1K 0.01% 256
2021
Q1 		$27K Hold
250
– – 0.01% 290
2020
Q4 		$20K Buy
250
+100
+67% +$9.82K 0.01% 294
2020
Q3 		$10K Hold
150
– – ﹤0.01% 357
2020
Q2 		$10K Buy
+150
New +$7.49K ﹤0.01% 363

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

AlphaMark Advisors's BNTX Position: Q4 2024 in Review

AlphaMark Advisors reduced its BioNTech (BNTX) stake by 79% in Q4 2024, selling an estimated $14.8K and leaving 35 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #524.

AlphaMark Advisors first reported a position in BNTX in Q2 2020 and has held it in 19 quarters since. The position peaked at $57K in Q4 2021. 303 funds tracked by Wall St. Rank hold BNTX as of Q4 2024.

  • AlphaMark Advisors held 35 shares of BioNTech worth $4K as of Q4 2024.
  • AlphaMark Advisors sold 130 BioNTech shares in Q4 2024, an estimated $14.8K.
  • BioNTech made up ﹤0.01% of AlphaMark Advisors's portfolio in Q4 2024, its #524 holding.
  • AlphaMark Advisors first reported a position in BioNTech in Q2 2020 and has held it in 19 quarters since.
  • AlphaMark Advisors's BioNTech position peaked at $57K in Q4 2021.
  • 303 funds tracked by Wall St. Rank held BioNTech as of Q4 2024.

Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.